KeyBanc raised the firm’s price target on HealthEquity (HQY) to $125 from $100 and keeps an Overweight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- Morning Movers: Chart Industries, Flowserve both rise following merger pact
- HealthEquity price target raised to $117 from $112 at RBC Capital
- HealthEquity price target raised to $125 from $110 at BofA
- Healthequity’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
- HealthEquity price target raised to $117 from $110 at Citizens JMP